PWPS
HRMY icon

Pinnacle Wealth Planning Services’s Harmony Biosciences HRMY Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.1K Buy
140
+42
+43% +$1.32K ﹤0.01% 2285
2026
Q1 		$2.75K Sell
98
-297
-75% -$9.74K ﹤0.01% 2387
2025
Q4 		$14.8K Buy
+395
New +$13K ﹤0.01% 1853

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pinnacle Wealth Planning Services's HRMY Position: Q2 2026 in Review

Pinnacle Wealth Planning Services increased its Harmony Biosciences (HRMY) stake by 43% in Q2 2026, buying an estimated $1.32K and bringing the position to 140 shares worth $5.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2285.

Pinnacle Wealth Planning Services first reported a position in HRMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $14.8K in Q4 2025. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Pinnacle Wealth Planning Services held 140 shares of Harmony Biosciences worth $5.1K as of Q2 2026.
  • Pinnacle Wealth Planning Services bought 42 Harmony Biosciences shares in Q2 2026, an estimated $1.32K.
  • Harmony Biosciences made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #2285 holding.
  • Pinnacle Wealth Planning Services first reported a position in Harmony Biosciences in Q4 2025 and has held it in 3 quarters since.
  • Pinnacle Wealth Planning Services's Harmony Biosciences position peaked at $14.8K in Q4 2025.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.